Clinical trial

Evaluate Efficacy and Safety of PA5108 Ocular Implants in Primary Open Angle Glaucoma or Ocular Hypertension

NCT06964191

StatusACTIVE_NOT_RECRUITING

Study typeINTERVENTIONAL

Start date2025-05-31

PhasePHASE2

Study timeline

Study start (actual)2025-05-31Date precision: day

Registry last updated2026-07-08

Observed by CureCurrent2026-10-07

Recorded dates are source observations, not predictions. Missing milestones are not estimated.

Conditions

Glaucoma, Open-Angleunresolved

Ocular Hypertensionunresolved

Interventions

PA5108 Ocular Implant low doseCOMBINATION_PRODUCT

PA5108 Ocular Implant, high doseCOMBINATION_PRODUCT

Latanoprost 0.005% Ophthalmic SolutionDRUG

Sponsors & collaborators

PolyActiva Pty Ltdlead sponsor

IUVO S.r.l.collaborator

Mapped research locations

Newport BeachCalifornia, United States1

Registry source

Open the source record to verify current eligibility, contacts, locations and registry updates.

Open NCT06964191 on ClinicalTrials.gov ↗

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.